1007-3418
2008 Issue 12
Five years follow-up of 220 chronic HBV carriers
LU Zhong-hua;CHEN Wei;DENG Jun;WANG Zhao-xia;PEI Hao;YANG Xiao-juan;ZHU Yin-fang;GU Xi-bing;HUANG Li-hua
LU Zhong-hua;CHEN Wei;DENG Jun;WANG Zhao-xia;PEI Hao;YANG Xiao-juan;ZHU Yin-fang;GU Xi-bing;HUANG Li-hua
..............page:881-884
The effect of telbivudine on peripheral blood CD4+CD25+ regulatory T cells and its significance in pa-tients with chronic hepatitis B
PAN Xiu-cheng;YANG Fan;CHEN Ming;FU Juan-juan;GUO Zhong-sheng;ZHANG Yan-chao;SUN Li-li
PAN Xiu-cheng;YANG Fan;CHEN Ming;FU Juan-juan;GUO Zhong-sheng;ZHANG Yan-chao;SUN Li-li
..............page:885-888
Correlation of polymorphisms of interleukin-2 gene and HBV DNA copies in patients with chronichepatitis B
WEI Ye-sheng;LAN Yan;YUAN Xi-hua;TANG Ren-guang;HUANG Zhong-min;WANG Chun-fang
WEI Ye-sheng;LAN Yan;YUAN Xi-hua;TANG Ren-guang;HUANG Zhong-min;WANG Chun-fang
..............page:889-892
Quantitive changes of circulating myeloid and plasmaeytoid dendritic cell subsets in HBV infected pa-tients during different periods of their infection
DONG Jin-ling;MA Li-na;GENG Nan;CHEN Xin-yue
DONG Jin-ling;MA Li-na;GENG Nan;CHEN Xin-yue
..............page:893-896
FibroTest-ActiTest for predicting liver fibrosis and inflammatory activity in Chinese patients with chronichepatitis B
GUI Hong-lian;XIE Qing;WANG Hui;ZHOU Hui-juan;CAI Wei;AN Bao-yan;JIANG Shan;XU Bei;LIN Zhi-mei;XU Yu-min
GUI Hong-lian;XIE Qing;WANG Hui;ZHOU Hui-juan;CAI Wei;AN Bao-yan;JIANG Shan;XU Bei;LIN Zhi-mei;XU Yu-min
..............page:897-901
Growth factors may enhance c-los and c-jun gene expressions of hepatic stellate cells
WANG Ai-min;PEN Chun-hai;XIANG Ying;WU Mei-li;ZHANG Zhi-wei;ZHU Zhi-jian;WANG Bao-en
WANG Ai-min;PEN Chun-hai;XIANG Ying;WU Mei-li;ZHANG Zhi-wei;ZHU Zhi-jian;WANG Bao-en
..............page:902-904
Application of 3.0F MRI 3D-VIBE dynamic contrast-enhanced in the diagnosis of small hepatocellular carcinomas
WANG Cheng-sheng;DUAN Qing;XUE Yun-jing;SUN Bin;HUANG Xin-ming;WANG Li-li
WANG Cheng-sheng;DUAN Qing;XUE Yun-jing;SUN Bin;HUANG Xin-ming;WANG Li-li
..............page:905-908
A study on the apoptosis of hepatoma cells synergistically induced by plasmid-mediated anti-angiogen-esis and immunopotentiation therapy
LI Pei-yuan;HUANG Huan-jun;ZHANG Qiong;WU Xiao-li;CHANG Ying;LIN Ju-sheng
LI Pei-yuan;HUANG Huan-jun;ZHANG Qiong;WU Xiao-li;CHANG Ying;LIN Ju-sheng
..............page:909-912
Effect of sFRP2 on the biological behavior of HepG2 cells
WEI Xiao-zhi;TAN Dong-mei;WANG Li-wei;PENG Hong-ying;LAI Guo-qi;TAN Yi
WEI Xiao-zhi;TAN Dong-mei;WANG Li-wei;PENG Hong-ying;LAI Guo-qi;TAN Yi
..............page:913-917
Inhibition effect of MIF antibody on the growth of hepatocellular carcinoma cell HepG2 in vitro
PENG Hong;YANG Zu-kui;HOU Jun;MA Guo-dong;CHENG Chun-yan
PENG Hong;YANG Zu-kui;HOU Jun;MA Guo-dong;CHENG Chun-yan
..............page:918-921
Frequencies of autoantibodies specific for primary biliary cirrhosis in a general adult population group
LIU Hai-ying;WANG Lu-xia;LIU Yun-feng;INVERNIZZI Pietro;XU De-xing;ZHONG Ren-qian;GONG Si-tang
LIU Hai-ying;WANG Lu-xia;LIU Yun-feng;INVERNIZZI Pietro;XU De-xing;ZHONG Ren-qian;GONG Si-tang
..............page:922-925
Monitoring vascular complications following liver transplantation using color Doppler flow imaging
REN Xiu-yun;ZOU Wei-long;ZING Yun-jin;CHEN Xin-guo;LI Xiao-mei;ZHANG Wei;ZHUANG Hui
REN Xiu-yun;ZOU Wei-long;ZING Yun-jin;CHEN Xin-guo;LI Xiao-mei;ZHANG Wei;ZHUANG Hui
..............page:926-929
Construction of p-hfgl2shRNA and its effect on hfgl2 expression in vitro
XI Dong;LI Li;GAO Sui;ZHU Chuan-long;GUO Jian-wen;WANG Ming;LUO Xiao-ping;N1NG Qin
XI Dong;LI Li;GAO Sui;ZHU Chuan-long;GUO Jian-wen;WANG Ming;LUO Xiao-ping;N1NG Qin
..............page:930-934
Effects of farnesoid X receptor on lipid metabolism in L02 cells
HONG Jiang-long;SHEN Wei;BAI Ming-jun
HONG Jiang-long;SHEN Wei;BAI Ming-jun
..............page:935-939
Clinical and pathological study of 30 patients with acute hy-dropic-type severe hepatitis
LIU Xu-hua;ZHANG Li-jie;WANG Tai-ling;CHEN Yi-sen;ZU Ke-jia;DUAN Zhong-ping
LIU Xu-hua;ZHANG Li-jie;WANG Tai-ling;CHEN Yi-sen;ZU Ke-jia;DUAN Zhong-ping
..............page:940-941
The effects of Ginkgo biloba extract on hepatic fibrosis in dia-betic rats
WANG Rong-rong;SU Zhi-tao;WANG Huan;WANG Wen-yan;WU Xiao-ye;WAN Li;CHEN Li-ling;CHEN Xiao-fei;CHEN Guo-rong
WANG Rong-rong;SU Zhi-tao;WANG Huan;WANG Wen-yan;WU Xiao-ye;WAN Li;CHEN Li-ling;CHEN Xiao-fei;CHEN Guo-rong
..............page:942-943
Role of CD163/HO-1 pathway in a rat acute liver failure model
GU Dian-na;CHEN Yong-ping;LU Ming-qin;ZHANG Lei;LU Jie;ZHENG Yi;ZHANG Xiao-hua
GU Dian-na;CHEN Yong-ping;LU Ming-qin;ZHANG Lei;LU Jie;ZHENG Yi;ZHANG Xiao-hua
..............page:944-945
The role of smae and its downstream pathway played in LPS induced apoptosis in L02 liver cells
CHEN Miao;TIAN De-ying;ZHANG Zhen-gang;ZHANG Shu-jun;WU Hui-ling;ZHOU Jian;LI Hui
CHEN Miao;TIAN De-ying;ZHANG Zhen-gang;ZHANG Shu-jun;WU Hui-ling;ZHOU Jian;LI Hui
..............page:946-947
The effects of curcumin on the expression of acetyi-CoA car-boxylase of HL-7702 cells
PENG Li-hong;YANG Xue-feng;FU Nian;WU Qing;LLAO Duan-fang;HE Juan;HUANG Qian-xiong;HU Yang
PENG Li-hong;YANG Xue-feng;FU Nian;WU Qing;LLAO Duan-fang;HE Juan;HUANG Qian-xiong;HU Yang
..............page:948-949
Expression of Pint-2 in normal liver and hepatoceliuinr carci-noma tissues
LI Bo;YE Tian;LI De-hua;SU Song;NI Jian-bin;XU Song-bo;LUO Liang;SHI Yu-jun;XI Jina-ping
LI Bo;YE Tian;LI De-hua;SU Song;NI Jian-bin;XU Song-bo;LUO Liang;SHI Yu-jun;XI Jina-ping
..............page:950-951
The application of HCV test strategy
YANG Fang;XING Wen-ge
YANG Fang;XING Wen-ge
..............page:952-954
terferon gamma and the treatment of hepatic fibrosis
WENG Hong-lei;CAI Wei-min
WENG Hong-lei;CAI Wei-min
..............page:953-957
SlRT1-a potential target for the therapy of nonalcoholic steatohepatitis
FENG Yi-yan;LI Hai
FENG Yi-yan;LI Hai
..............page:958-960